At this time, posts about iCure are rapidly increasing on portals and stock communities, while foreign investors are tentatively reported to have net sold 7,000 shares today. iCure is known as a company possessing core technology for transdermal drug delivery systems.

As of 11:30 AM on the 20th, iCure's stock price is 28,550 KRW, up 14.2% from the previous day, with a trading volume of 1,079,464 shares, which is 2016.33% of the 5-day average trading volume.

In addition to iCure, posts from investors are also surging regarding Dongyang Steel Pipe (008970), Powernet (037030), and UbiCare (032620).

※Source: AI Investment Assistant AI Lassi

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing